SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001054074-23-000009
Filing Date
2023-09-20
Accepted
2023-09-20 10:55:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2865
  Complete submission text file 0001054074-23-000009.txt   4063
Mailing Address
Business Address
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 144

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38410 | Film No.: 231265603
SIC: 2834 Pharmaceutical Preparations